Three 2024 trials spanning enteral protein dosing (a major harm-signal trial), tranexamic acid for variceal bleeding in cirrhosis, and a smaller contrasting positive protein-dosing trial, summarized in full CCR 11-part format.
PRECISe — High vs Standard Protein Provision in Critical IllnessKumar et al. — Tranexamic Acid for Upper GI Bleeding in CirrhosisWang et al. — Early High Protein Intake in Critically Ill Patients🧬